Effect of Caffeine and Aminophylline on Apnea of Prematurity

Document Type : Original Article

Authors

1 Kosar Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

2 Qazvin Children Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

Abstract

Background: The most common type of apnea among premature newborns is idiopathic apnea of prematurity. Recurrent apnea can lead to hypoxemia and central nervous system damage. Although caffeine and theophylline are the most commonly prescribed drugs in this field, there is disagreement about which medicine is preferred. The purpose of this study was to compare the therapeutic effect and side effects of caffeine and aminophylline in the treatment of idiopathic apnea of prematurity.
Methods: This randomized clinical trial study was conducted on 67 premature neonates with the definite diagnosis of idiopathic apnea of prematurity. In this regard, subjects were divided into two groups, namely aminophylline recipient group (n=31) and caffeine recipient group (n=36). The two groups were compared regarding the frequency of recurrent apnea and side effects of drugs.
Results: Regarding gender distribution, 15 (48.4%) patients in the aminophylline recipient group, and subjects in the 20 (55.6%) caffeine recipient group were male. After the treatment, apnea recurred only in one case (0.1%) of aminophylline recipient group. Moreover, 7 patients (58.3%) in the aminophylline recipient group and 5 cases (41%) in the caffeine recipient group suffered from gastrointestinal side effects (P=0.3).
Conclusion: The obtained results of the present study revealed that there was no significant difference between the two groups.

Keywords

References

1. Patrinos ME. Respiratory disorders in preterm and term infants. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Fanaroff and Martin’s neonatal-perinatal medicine diseases of the fetus and infant. Philadelphia: Saunders; 2015. P. 1140-7.
 2. Kliegman RM, Behrman RE, Jenson HB, Stanton BM. Nelson textbook of pediatrics. 20th ed. New York: Elsevier Health Sciences; 2016. P. 849-50.
3. Zhao J, Gonzalez F, Mu D. Apnea of prematurity: from cause to treatment. Eur J Pediatr. 2011; 170(9):1097-105.
4. Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CM. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. Paediatr Drugs. 2014; 16(2):169-77.
 5. Skouroliakou M, Bacopoulou F, Markantonis SL. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial. J Paediatr Child Health. 2009; 45(10):587-92.
 6. Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev. 2010; 20(1):CD000273.
 7. Hascoet JM, Hamon I, Boutroy MJ. Risks and benefits of therapies for apnoea in premature infants. Drug Saf. 2000; 23(5):363-79.
8. Gannon BA. Theophylline or caffeine: which is best for apnea of prematurity? Neonatal Netw. 2000; 19(8):33-6.
9. Laubscher B, Greenough A, Dimitriou G. Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants. Early Human Dev. 1998; 50(2):185-92.
10. Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, et al. High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2004; 89(6):F499-503.
11. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006; 354(20): 2112-21.
 12. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007; 357(19):1893-902.
13. Hoecker C, Nelle M, Poeschl J, Beedgen B, Linderkamp O. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics. 2002; 109(5):784-7.
14. Saliba E, Autret E, Gold F, Bloc D, Pourcelot L, Laugier J. Effect of caffeine on cerebral blood flow velocity in preterm infants. Biol Neonate. 1989; 56(4):198-203.
15. Kulkarni PB, Dorand RD. Caffeine toxicity in a neonate. Pediatrics. 1979; 64(2):254-5.
 16. Carnielli VP, Verlato G, Benini F, Rossi K, Cavedagni M, Filippone M, et al. Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2000; 83(1):F39-43.
 17. Bauer J, Maier K, Linderkamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001; 107(4):660-3.
Iranian Journal of Neonatology
Volume 10, Issue 2
June 2019
Pages 37-41

Files

Share

How to cite

Statistics